| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | EX-527 | GDSC1000 | pan-cancer | AAC | -0.039 | 0.2 |
| mRNA | tigecycline | CTRPv2 | pan-cancer | AAC | 0.063 | 0.2 |
| mRNA | lenalidomide | GDSC1000 | pan-cancer | AAC | -0.04 | 0.3 |
| mRNA | S-Trityl-L-cysteine | GDSC1000 | pan-cancer | AAC | -0.059 | 0.3 |
| mRNA | CAY10594 | CTRPv2 | pan-cancer | AAC | -0.049 | 0.3 |
| mRNA | PFI-1 | GDSC1000 | pan-cancer | AAC | 0.037 | 0.3 |
| mRNA | FQI-1 | CTRPv2 | pan-cancer | AAC | -0.059 | 0.3 |
| mRNA | XAV-939 | GDSC1000 | pan-cancer | AAC | -0.038 | 0.3 |
| mRNA | Tamoxifen | GDSC1000 | pan-cancer | AAC | -0.037 | 0.3 |
| mRNA | Bryostatin 1 | GDSC1000 | pan-cancer | AAC | 0.039 | 0.3 |